Inventor
Stephen W. Burgess
Inventor
Chelsea, AL, US
Overview
Patents· 14 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
C07HSugars7%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for5%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07CAcyclic or carbocyclic compounds2%
C12NMicroorganisms or enzymes2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,739,353Suppression of cytokine release and cytokine storm202010,463,738Oral composition for delivery of drugs and other substances201910,258,691Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies201910,143,744Disaccharide synthetic lipid compounds and uses thereof20189,872,908Oral composition for delivery of drugs and other substances20189,518,078'Disaccharide synthetic lipid compounds and uses thereof'20169,403,760'Compounds'20169,241,988'Disaccharide synthetic lipid compounds and uses thereof'20168,222,233'Modifications of solid 3-sn-phosphoglycerides'20127,947,306'Modifications of solid 3-sn-phosphoglycerides'20117,785,621'Oral compositions of fenretinide having increased bioavailability and methods of using the same'20107,780,978'Oral pharmaceutical compositions and methods of using the same'20107,407,779'Modification of solid 3-sn-phosphoglycerides'20085,948,878'Cationic polymers for nucleic acid transfection and bioactive agent delivery'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999Based in Montevallo, AL, US· patent location history
2008–2012Patents assigned to BIOMOLECULAR PRODUCTS INC (3)· patent assignee history
2008–2012Based in Columbiana, AL, US· patent location history
2010Patents assigned to LOS ANGELES CHILDRENS HOSPITAL (2)· patent assignee history
2010–2020Based in Chelsea, AL, US· patent location history
2016–2020Patents assigned to AVANTI POLAR LIPIDS INC (8)· patent assignee history
2016–2018Patents assigned to AC IMMUNE SA (3)· patent assignee history
2019–2020Patents assigned to SIGNPATH PHARMA INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AVANTI POLAR LIPIDS INC | 8 | 2016–2020 |
| AC IMMUNE SA | 3 | 2016–2018 |
| BIOMOLECULAR PRODUCTS INC | 3 | 2008–2012 |
| LOS ANGELES CHILDRENS HOSPITAL | 2 | 2010 |
| SIGNPATH PHARMA INC | 2 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chelsea, AL, US | 10 | 2010–2020 |
| Columbiana, AL, US | 3 | 2008–2012 |
| Montevallo, AL, US | 1 | 1999 |